Home › Stock analysis › RGC
Regencell Bioscience (RGC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $9.59, +0.74% vs the prior close of $9.52.
- Volume 681.76K shares, 3.1x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RGC rises 0.7% to $9.59, a 3-month high on 3.1x normal volume. Closed at $9.59, +0.74% vs the prior close of $9.52. Day range $8.83–$10.33, opened at $10.18.
Last close$9.59+0.74%
Day range8.83–10.33
Open10.18
Volume681.76K
52-week range4.51–69.00
Avg volume (20d)310.58K
RGC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — RGC rises 0.7% to $9.59, a 3-month high on 3.1x normal volume
- Closed at $9.59, +0.74% vs the prior close of $9.52. Day range $8.83–$10.33, opened at $10.18.
- Volume was 681.76K shares, 3.1x its 50-day average of 220.34K — unusually heavy trading.
- Price is +54.2% vs its 50-day average ($6.22) and -48.1% vs its 200-day average ($18.49).
- 52-week range $4.51–$69.00; today's close sits at 8% of that range, 86.1% below the 52-week high.
Oct 15, 2026 — RGC jumps 17.4% to $9.52, a 3-month high on 10.2x normal volume
- Closed at $9.52, +17.39% vs the prior close of $8.11. Day range $7.72–$11.12, opened at $7.98.
- Volume was 1.91M shares, 10.2x its 50-day average of 188.14K — unusually heavy trading.
- Price is +55.1% vs its 50-day average ($6.14) and -48.7% vs its 200-day average ($18.56).
- 52-week range $4.51–$69.00; today's close sits at 8% of that range, 86.2% below the 52-week high.
Oct 14, 2026 — RGC dips 1.0% to $8.11 on 3.7x normal volume
- Closed at $8.11, -0.98% vs the prior close of $8.19. Day range $7.82–$9.47, opened at $8.20.
- Volume was 657.40K shares, 3.7x its 50-day average of 179.63K — unusually heavy trading.
- Price is +33.7% vs its 50-day average ($6.07) and -56.5% vs its 200-day average ($18.63).
- 52-week range $4.51–$69.00; today's close sits at 6% of that range, 88.2% below the 52-week high.
Oct 13, 2026 — RGC jumps 14.9% to $8.19, a 3-month high on 3.3x normal volume
- Closed at $8.19, +14.87% vs the prior close of $7.13. Day range $7.09–$8.65, opened at $7.16.
- Volume was 577.40K shares, 3.3x its 50-day average of 173.95K — unusually heavy trading.
- Price is +36.0% vs its 50-day average ($6.02) and -56.2% vs its 200-day average ($18.69).
- 52-week range $4.51–$69.00; today's close sits at 6% of that range, 88.1% below the 52-week high.
Oct 12, 2026 — RGC dips 3.0% to $7.13
- Closed at $7.13, -2.99% vs the prior close of $7.35. Day range $6.82–$7.40, opened at $7.23.
- Volume was 129.90K shares, 0.7x its 50-day average of 175.18K.
- Price is +19.2% vs its 50-day average ($5.98) and -62.0% vs its 200-day average ($18.78).
- 52-week range $4.51–$69.00; today's close sits at 4% of that range, 89.7% below the 52-week high.
Oct 9, 2026 — RGC slides 3.7% to $7.35
- Closed at $7.35, -3.67% vs the prior close of $7.63. Day range $7.28–$7.75, opened at $7.73.
- Volume was 117.90K shares, 0.7x its 50-day average of 176.32K.
- Price is +23.2% vs its 50-day average ($5.96) and -61.0% vs its 200-day average ($18.87).
- 52-week range $4.51–$69.00; today's close sits at 4% of that range, 89.3% below the 52-week high.
Oct 8, 2026 — RGC jumps 7.3% to $7.63, a 3-month high
- Closed at $7.63, +7.31% vs the prior close of $7.11. Day range $7.06–$7.96, opened at $7.06.
- Volume was 223.70K shares, 1.3x its 50-day average of 175.32K.
- Price is +28.5% vs its 50-day average ($5.94) and -59.7% vs its 200-day average ($18.94).
- 52-week range $4.51–$69.00; today's close sits at 5% of that range, 88.9% below the 52-week high.
Oct 7, 2026 — RGC slides 3.3% to $7.11
- Closed at $7.11, -3.27% vs the prior close of $7.35. Day range $7.01–$7.35, opened at $7.35.
- Volume was 109.80K shares, 0.6x its 50-day average of 176.39K.
- Price is +20.6% vs its 50-day average ($5.90) and -62.6% vs its 200-day average ($19.00).
- 52-week range $4.51–$69.00; today's close sits at 4% of that range, 89.7% below the 52-week high.
- SEC filings that day: 20-F.
Oct 6, 2026 — RGC rises 1.5% to $7.35, a 3-month high, 5 up days in a row
- Closed at $7.35, +1.52% vs the prior close of $7.24. Day range $6.84–$7.92, opened at $7.22.
- Volume was 300.70K shares, 1.7x its 50-day average of 174.42K.
- Price is +25.1% vs its 50-day average ($5.87) and -61.4% vs its 200-day average ($19.06).
- 52-week range $4.51–$69.00; today's close sits at 4% of that range, 89.3% below the 52-week high.
- That makes 5 straight gains.
Oct 5, 2026 — RGC jumps 6.2% to $7.24, a 3-month high, 4 up days in a row
- Closed at $7.24, +6.16% vs the prior close of $6.82. Day range $6.46–$7.40, opened at $6.72.
- Volume was 307.20K shares, 1.8x its 50-day average of 171.52K.
- Price is +23.9% vs its 50-day average ($5.84) and -62.1% vs its 200-day average ($19.11).
- 52-week range $4.51–$69.00; today's close sits at 4% of that range, 89.5% below the 52-week high.
- That makes 4 straight gains.
Oct 2, 2026 — RGC jumps 7.7% to $6.82 on 2.6x normal volume
- Closed at $6.82, +7.74% vs the prior close of $6.33. Day range $6.22–$7.39, opened at $6.37.
- Volume was 425.80K shares, 2.6x its 50-day average of 166.14K — unusually heavy trading.
- Price is +17.3% vs its 50-day average ($5.81) and -64.4% vs its 200-day average ($19.16).
- 52-week range $4.51–$69.00; today's close sits at 4% of that range, 90.1% below the 52-week high.
- That makes 3 straight gains.
RGC latest news & SEC filings
Every SEC filing by or about RGC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 20-F — Annual report from a foreign company (20-F)
Annual report from a foreign company (20-F)
Fiscal year ended Jun 30, 2026:
- Net income: -$11.70M (prior year -$3.58M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$2.37 (prior year -$0.72) (loss widened vs Jun 30, 2025)
Things to know before you trade RGC
- How much it moves: over the last 20 sessions the average daily move was 4.19% (largest 17.4%). That is a volatile stock.
- Liquidity: about 310.58K shares (≈$2.98M) trade per day on average.
- 52-week position: $9.59 vs a range of $4.51–$69.00 (8% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 38:1 on Jun 16, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 20-F Oct 7, 2026; 6-K May 22, 2026; 6-K May 19, 2026.
- Listing: Nasdaq · industry: Medicinal Chemicals & Botanical Products.
RGC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 10.18 | 10.33 | 8.83 | 9.59 | 681.76K |
| Oct 15, 2026 | 7.98 | 11.12 | 7.72 | 9.52 | 1.91M |
| Oct 14, 2026 | 8.20 | 9.47 | 7.82 | 8.11 | 657.40K |
| Oct 13, 2026 | 7.16 | 8.65 | 7.09 | 8.19 | 577.40K |
| Oct 12, 2026 | 7.23 | 7.40 | 6.82 | 7.13 | 129.90K |
| Oct 9, 2026 | 7.73 | 7.75 | 7.28 | 7.35 | 117.90K |
| Oct 8, 2026 | 7.06 | 7.96 | 7.06 | 7.63 | 223.70K |
| Oct 7, 2026 | 7.35 | 7.35 | 7.01 | 7.11 | 109.80K |
| Oct 6, 2026 | 7.22 | 7.92 | 6.84 | 7.35 | 300.70K |
| Oct 5, 2026 | 6.72 | 7.40 | 6.46 | 7.24 | 307.20K |
| Oct 2, 2026 | 6.37 | 7.39 | 6.22 | 6.82 | 425.80K |
| Oct 1, 2026 | 6.30 | 6.43 | 6.12 | 6.33 | 67.70K |
| Sep 30, 2026 | 6.24 | 6.25 | 6.14 | 6.22 | 56.10K |
| Sep 29, 2026 | 6.11 | 6.30 | 6.07 | 6.20 | 53.40K |
| Sep 28, 2026 | 6.15 | 6.30 | 6.05 | 6.20 | 76.00K |
| Sep 25, 2026 | 6.25 | 6.25 | 6.05 | 6.17 | 51.10K |
| Sep 24, 2026 | 6.08 | 6.26 | 5.91 | 6.17 | 91.10K |
| Sep 23, 2026 | 6.14 | 6.16 | 5.92 | 5.98 | 134.10K |
| Sep 22, 2026 | 5.90 | 6.40 | 5.86 | 6.23 | 126.30K |
| Sep 21, 2026 | 5.74 | 6.05 | 5.66 | 5.92 | 113.30K |
About Regencell Bioscience
Regencell Bioscience (RGC) is listed on the Nasdaq and classified by the SEC under “Medicinal Chemicals & Botanical Products”. Its business address is in HONG KONG. State of incorporation: Cayman Islands. Fiscal year ends —. SEC CIK 1829667.
RGC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Yat-Gai Au | Chief Executive Officer | Mar 18, 2026 |
| James Wai Hong Chung | COO and Chief Strategy Officer | Mar 18, 2026 |
| Evana Yee Wah Hui | Director | May 29, 2026 |
| Margaret Hoor Han Lo | Director | Mar 18, 2026 |
| William Wing Yan Dr Lo | Director | May 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Yat-Gai Au | Chief Executive Officer | Mar 18, 2026 |
| Yat-Pui Au | Chief Business Officer | Mar 18, 2026 |
| Ho Yau Chan | Financial Controller | Mar 18, 2026 |
| James Wai Hong Chung | COO and Chief Strategy Officer | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
RGC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
RGC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Medicinal Chemicals & Botanical Products
Definium Therapeutics (DFTX)Trulieve Cannabis (TRLV)Tilray Brands (TLRY)IM Cannabis (IMCC)Glass House Brands (GLAS)Aurora Cannabis (ACB)Cronos (CRON)Usana Health Sciences (USNA)Canopy Growth (CGC)Sndl (SNDL)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on RGC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.